Stem Cell Banking Market by Type, Service, Source, Application – Global …

The Stem Cell Banking Market was valued at USD 14.54 billion in 2023, expected to reach USD 16.98 billion in 2024, and is projected to grow at a CAGR of 17.22%, to USD 44.24 billion by 2030. The stem cell banking market is defined by the collection, processing, and storage of stem cells for potential future medical use, often involving umbilical cord blood, embryonic stem cells, and adult stem cells. The necessity of stem cell banking stems from its potential in regenerative medicine and treatment of a wide array of genetic disorders, blood-related diseases, and degenerative conditions. Applications extend to personalized medicine, research initiatives, and therapeutic developments, with significant end-user demographics including hospitals, research laboratories, and biotechnology firms. Key growth influences encompass advancements in stem cell research and therapies, increasing awareness of cord blood banking benefits, and expanding investments by governmental and private organizations

Read more
ViaCord Cord Blood Banking

Stem Cell Transplants Cord blood stem cells can be used in the treatment of nearly 80 conditions to regenerate healthy blood and immune system. ... Disclaimer: Banking cord blood does not guarantee that treatment will work and only a doctor can determine when it can be used. Cord tissue stem cells have not been used in treatment yet.

Read more
What Is Stem Cell Banking? – Celltex Therapeutics Corporation

Celltex News What Is Stem Cell Banking? Posted on Jun 24th, 2024 In 1992, Dr. Pablo Rubinstein established the first public stem cell bank, the National Cord Blood Program (NCBP), at the New York Blood Center with funding provided by the National Heart, Lung and Blood Institute (NHLBI) of the National Institutes of Health (NIH) [1]. The NCBP was founded to investigate the potential medical uses of cord blood with the primary goal of ascertaining if cord blood could serve as an alternate source for hematopoietic stem cell transplants for patients without matched bone marrow donors

Read more